The Asia Pacific Blood Warmer Market would witness market growth of 8.8% CAGR during the forecast period (2023-2030).
One of the key factors driving the market's growth is the rising number of newborns around the world, as these blood warmers are utilized in hospitals and clinics by medical experts during treatments like blood transfusions and others in infants. According to UNICEF, approximately 67,385 infants are born daily in India, representing one-sixth of the global total. Unfortunately, one of these infants dies every minute which is a critical problem rapidly escalating due to the lack of adequate healthcare facilities. Therefore, these factors are projected to spur market expansion in the upcoming years.
Cold liquids inhibit the immune response and can increase susceptibility to disease. By warming the blood and other fluids, blood warmer can reduce the chance of getting sick and improve the body's defenses against viruses and bacteria. Patients' blood and fluid temperatures can quickly decrease in colder climates, leading to hypothermia. A blood warmer can aid in preventing hypothermia by keeping the blood and fluids at a safe temperature. The rising elderly and newborn populations are driving the market, the increase in surgeries, and the rise in trauma cases. All these factors will uplift the market expansion in upcoming years.
The age range most severely hit by road accidents is 18 to 45 years old, accounting for almost 67 percent of unintentional fatalities. China’s total number of motor vehicles climbed by 68.12% over ten years, from 207 million in 2010 to 348 million in 2019. As a result, one of the largest public health concerns in the APAC area has been road safety. As a result, one of the largest public health concerns in the APAC area has been road safety. The rising incidence of road accidents further raise the need for surgical procedures in the region and thus the demand in APAC also rises.
The China market dominated the Asia Pacific Blood Warmer Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $137.3 million by 2030. The Japan market is showcasing a CAGR of 8.1% during (2023 - 2030). Additionally, The India market would exhibit a CAGR of 9.4% during (2023 - 2030).
Based on Application, the market is segmented into Surgery, Acute Care, New Born Care, Homecare, and Others. Based on Product, the market is segmented into Non-portable Blood/IV Warmers, and Portable Blood/IV Warmers. Based on End-use, the market is segmented into Hospitals/Clinic, Ambulatory Services, Defense Forces, and Rescue Forces. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Blood Warmer Market is Projected to reach USD 1.8 Billion by 2030, at a CAGR of 7.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Stryker Corporation, ICU Medical, Inc., Gentherm Incorporated (Gentherm Medical), Vyaire Medical, Inc. (Apax Partners LLP), Belmont Medical Technologies (Audax Management Company, LLC.), The Surgical Company, Life Warmer, Estill Medical Technologies, Inc., and Smisson-Cartledge Biomedical, LLC.
By Application
By Product
By End-use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 